🇺🇸 FDA
Drug

capivasertib

Brand: TRUQAP

approved

Quick answer

capivasertib (TRUQAP), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
capivasertib
Brand
TRUQAP
Route
ORAL
Formulation
TABLET

Related news

FDA Advisory Committee Recommends AstraZeneca's TRUQAP for PTEN-Deficient Prostate Cancer
NewsOncology - Prostate CancerMay 1, 2026

FDA Advisory Committee Recommends AstraZeneca's TRUQAP for PTEN-Deficient Prostate Cancer

FDA Advisory Committee votes 7-1 to recommend AstraZeneca's TRUQAP (capivasertib) for PTEN-deficient metastatic hormone-sensitive prostate cancer patients.

James Chen, PharmD

Frequently asked questions

What is capivasertib?

capivasertib (TRUQAP), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for capivasertib?

TRUQAP is a marketed brand name for capivasertib. Check FDA Drugs@FDA for the current US label holder.